Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HOTH - Hoth Therapeutics' human trial underway evaluating BioLexa for eczema

HOTH - Hoth Therapeutics' human trial underway evaluating BioLexa for eczema

Hoth Therapeutics Inc.
Hoth Therapeutics (HOTH) starts its First in Human clinical trial investigating topical BioLexa for the treatment of mild to moderate atopic dermatitis, also known as eczema. The trial is being conducted in Australia.

For further details see:

Hoth Therapeutics' human trial underway evaluating BioLexa for eczema
Stock Information
Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NASDAQ
Website: hoththerapeutics.com
Menu
HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...